Diagnosis and management of chronic pelvic pain

Urologic Clinics of North America

Volumn 29, Issue 3, 2002, Pages 637-647

  Loeb Lifford, Karen ^a,b   Barbieri, Robert L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AZATHIOPRINE; CORTICOSTEROID; DANAZOL; DIMETHYL SULFOXIDE; GONADORELIN AGONIST; HEPARIN; IBUPROFEN; LEUPRORELIN; MEDROXYPROGESTERONE ACETATE; NAFARELIN ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; NORETHISTERONE ACETATE; NORGESTREL; ORAL CONTRACEPTIVE AGENT; PENTOSAN POLYSULFATE; SEROTONIN ANTAGONIST; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT;

BONE DENSITY; BONE DISEASE; DEPRESSION; DIAGNOSTIC VALUE; EMOTIONAL STRESS; ESTROGEN BLOOD LEVEL; EVALUATION; FEMALE; GASTROINTESTINAL DISEASE; GYNECOLOGIC DISEASE; HEADACHE; HORMONE RESPONSE; HUMAN; INSOMNIA; LIBIDO DISORDER; MUSCULOSKELETAL DISEASE; NARCOTIC DEPENDENCE; PATIENT REFERRAL; PELVIS PAIN SYNDROME; PHYSICAL EXAMINATION; PHYSICAL STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SEXUAL ABUSE; STATISTICAL MODEL; SYMPTOMATOLOGY; UROLOGY; VAGINA DISEASE; VASOMOTOR DISORDER;

CHRONIC DISEASE; FEMALE; HUMANS; PELVIC PAIN;

EID: 0036704145     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(02)00054-X     Document Type: Review

References (82)

1. Zondervan KT, Yudkin PL, Vessey MP, et al. Chronic pelvic pain in the community-symptoms, investigations and diagnoses. Am J Obstet Gynecol 2001;184:1149-55.
2. Mathias SD, Kuppermann M, Liberman RF, et al. Chronic pelvic pain: Prevalence, health-related quality of life and economic correlates. Obstet Gynecol 1996;87:321-7.
3. Zondervan KT, Yudkin PL, Vessey MP, et al. Prevalence and incidence of chronic pelvic pain in primary care: Evidence from a national general practice database. Br J Obstet Gynecol 1999;106:1149-55.
4. Koninckx PR, Meuleman C, Demeyere S, et al. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil Steril 1991;55:759-65.
5. Ling FW. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Obstet Gynecol 1999;93:51-8.
6. Stacey CM, Munday PE. Abdominal pain in women attending a genitourinary medicine clinic: Who has PID? In J STD AIDS 1994;5:338-42.
7. Thompson WG. Irritable bowel syndrome, prevalence, prognosis and consequences. CMAJ 1986;134:111-3.
8. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders: Prevalence, sociodemography and health impact. Dig Dis Sci 1993;38:1569-80.
9. Horwitz BJ, Fisher RS. Current concepts: The irritable bowel syndrome. New Engl J Med 2001; 334:1846-50.
10. Taub E, Cuevas JL, Cook EW, et al. Irritable bowel syndrome defined by factor analysis. Dig Dis Sci 1995;40:2647-55.
11. Talley NJ, Phillips SF, Melton LJ, et al. Diagnostic criteria of the Manning criteria in irritable bowel syndrome. Gut 1990;31:77-81.
12. Manning AP, Thompson WG, Heaton KW, et al. Towards a positive diagnosis of irritable bowel. BMJ 1978;2:653-4.
13. Devesa SS, Silverman DT, Young JL Jr, et al. Cancer incidence and mortality trends among whites in the United States, 1946-84. J Natl Cancer Inst 1987;79:701-70.
14. Paterson WG, Thompson WG, Vanner SJ, et al. Recommendations for the management of irritable bowel syndrome in family practice. CMAJ 1999;161:154-60.
15. Horwitz BJ, Fisher RS. Current concepts: The irritable bowel syndrome. New Engl J Med 2001; 334:1846-50.
16. De Ponti F, Tonini M. Irritable bowel syndrome: New agents targeting seratonin receptor subtypes. Drugs 2001;61:317-32.
17. Thompson CA. Alosetron withdrawn from market. Am J Health Syst Pharm 2001;58:13.
18. Prather CM, Camilleri M, Zinsmeister AR, et al. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000;118:463-8.
19. Desautels S, Wald A. Treatment of Irritable Bowel Syndrome. Wellesley, MA: Up To Date; 2001.
20. Sant G, Theoharides TC. Interstitial cystitis. Curr Opin Urol 1999;9:297-302.
21. Jones CA, Nyberg L. Epidemiology of interstitial cystitis. Urology 1997;49:2-9.
22. Van de Merwe J, Kamerling R, Arendsen E, et al. Sjogren's syndrome in patients with interstitial cystitis. J Rheumatol 1993;20:962-6.
23. Ratliff TL, Klutke CG, Hofmeister M, et al. Role of the immune response in interstitial cystitis. Clin Immunol Immunopathol 1995;74:209-16.
24. Matilla J. Vascular immunopathology in interstitial cystitis. Clin Immunol Immunopathol 1982;23:648-55.
25. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases workshop on interstitial cystitis. J Urol 1988;140:203-6.
26. Parsons CL. Interstitial cystitis. In: Kursh ED, McGuire EJ, editors. Female Urology. Philadelphia: JB Lippincott; 1994. p. 421-38.
27. Messing EM, Stamey TA. Interstitial cystitis, early diagnosis, pathology and treatment. Urology 1978;12:381-92.
28. Chambers GK, Fenster HN, Cripps SJ, et al. An assessment of the use of intravesical potassium in the diagnosis of interstitial cystitis. J Urol 1999;162:699-701.
29. Hanno PM, Buehler J, Wein AJ. Interstitial cystitis, Part I and II. Urol Clin North Am 1994;21:124-41.
30. Jones CA, Nyberg L. Epidemiology of interstitial cystitis. Urology 1997;49:2-9.
31. Fowler Jr JE. Prospective study of intravesical dimethyl sulfoxide in treatment of suspected early interstitial cystitis. Urology 1981;18:21-6.
32. Parkin J, Shea C, Sant GR. Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis: A practical approach. Urology 1997;49:105-7.
33. Sant GR, LaRock DR. Standard intravesical therapies for interstitial cystitis. Urol Clin North Am 1994;21:73-83.
34. Hanno PM. Diagnosis of interstitial cystitis. Urol Clin North Am 1994;21:63-6.
35. Soltes BA, Ruderman EM, Johnson PW, et al. Fibromyalgia syndrome (FMS) symptomatology in women with chronic pelvic pain. Arthritis Rheum 1999;42:S343.
36. Katz RS, Ruderman EM, Frasor J, et al. Pelvic tenderness in women with chronic pelvic pain correlates with fibromyalgia syndrome (FMS) tenderness. Arthritis Rheum 1999;42:S150.
37. Slocumb JC. Neurologic factors in chronic pelvic pain: Trigger points and the abdominal pain syndrome. Am J Obstet Gynecol 1984;149:536-43.
38. Applegate WV. Abdominal cutaneous nerve entrapment syndrome. Surgery 1972;71:118-24.
39. Slocumb JC. Chronic somatic, myofacial and neurogenic abdominal pelvic pain. Clin Obstet Gynecol 1990;33:145-53.
40. Martin DC, Hubert GD, Vander Zwaag R, et al. Laparoscopic appearances of peritoneal endometriosis. Fertil Steril 1989;51:63-7.
41. Stripling MC, Martin DC, Chatman DL, et al. Subtle appearance of pelvic endometriosis. Fertil Steril 1988;49:427-31.
42. Jansen RP, Russell P. Nonpigmented endometriosis: Clinical, laparoscopic, and pathologic definition. Am J Obstet Gynecol 1986;155:1154-9.
43. Barbieri RL, Propst AM. Physical examination findings in women with endometriosis: Uterosacral ligament abnormalities, lateral cervical displacement and cervical stenosis. J Gynecol Tech 1999;5:157.
44. Propst AM, Storti K, Barbieri RL. Lateral cervical displacement is associated with endometriosis. Fertil Steril 1998;70:568.
45. Barbieri RL, Callery M, Perez SE. Directionality of menstrual flow: Cervical os diameter as a determinant of retrograde menstruation. Fertil Steril 1992;57:727.
46. Buttram VC Jr, Reiter RC. Uterine leiomyomata: Etiology, symptomatology and management. Fertil Steril 1981;36:433-45.
47. Acien P, Quereda F. Abdominal myomectomy: Results of a simple operative technique. Fertil Steril 1996;65:41-51.
48. Smith DC, Uhlir JK. Myomectomy as a reproductive procedure. Am J Obstet Gynecol 1990;162:1476-9.
49. Westrom L, Joeseof R, Reynolds G, et al. Pelvic inflammatory disease and fertility. Sex Transm Dis 1992;19:185-92.
50. Safrin S, Schachter J, Dahrouge D, et al. Long-term sequelae of acute pelvic inflammatory disease: A retrospective cohort study. Am J Obstet Gynecol 1992;166:1300-5.
51. Buchan H, Vessey M, Goldacre M, et al. Morbidity following pelvic inflammatory disease. Br J Obstet Gynecol 1993;100:558-62.
52. Peters AA, Trimbos-Kemper GC, Admiraal C, et al. A randomized clinical trial on the benefit of adhesiolysis in patients with intraperitoneal adhesions and chronic pelvic pain. Br J Obstet Gynecol 1992;99:59-62.
53. Porpora MG, Gomel V. The role of laparoscopy in the management of pelvic pain in women of reproductive age. Fertil Steril 1997;68:765-9.
54. Pardanani S, Barbieri RL. The gold standard for the surgical diagnosis of endometriosis: Visual findings or biopsy results? J Gynecol Tech 1998;4:121.
55. Morales AJ, Murphy AA. Endoscopic treatment for endometriosis. Obstet Gynecol Clin North Am 1999; 26:121-3.
56. Sutton CJ, Ewen SP, Whitelaw N, et al. Prospective randomized double blind controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild and moderate endometriosis. Fertil Steril 1994;62:696.
57. Candiani GB, Fedele L, Vercellini P, et al. Presacral neurectomy for the treatment of pelvic pain associated with endometriosis: A controlled study. Am J Obstet Gynecol 1992;167:100-3.
58. Peter AAW, Trimbos-Kemper GCM, Admiral C, et al. A randomized clinical trial on the benefit of adhesiolysis in patients with intraperitoneal adhesions and chronic pelvic pain. Br J Obstet Gynecol 1992;99:59-62.
59. Kapur BML, Rai PC, Gulati SM. Prevention of experimental peritoneal adhesions by low molecular dextran. Int Surg 1967;48:264.
60. Reading AE, The internal structure of the McGill pain questionnaire in dysmenorrhea patients. Pain 1979;7:353-8.
61. Carlson KJ, Miller BA, Fowler FJ. The Maine Women's Health Study: I Outcomes of hysterectomy. Obstet Gynecol 1994;83:556-65.
62. Kjerluff KH, Langenberg PW, Rhodes JC, et al. Effectiveness of hysterectomy. Obstet Gynecol 2000; 95:319-26.
63. Tay SK, Bromwich N. Outcome of hysterectomy for pelvic pain in premenopausal women. Aust N Z J Obstet Gynecol 1998;38:72-6.
64. Stovall TG, Ling FW, Crawford DA. Hysterectomy for chronic pelvic pain of presumed uterine etiology. Obstet Gynecol 1990;75:676-9.
65. Kistner RW. The treatment of endometriosis by inducing pseudopregnancy with ovarian hormones: A report of 58 cases. Fertil Steril 1959;10:539-66.
66. Noble AD, Letchworth AT. Medical treatment of endometriosis: A comparative trial. Postgrad Med J 1979;55:37-9.
67. Vercellini P, Trespidi L, Colombo A, et al. A gonadotropin releasing hormone agonist versus a low dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril 1993;60:75-9.
68. Farquhar CM, Rogers V, Franks S, et al. A randomized controlled trial of medroxyprogesterone acetate and psychotherapy for the treatment of pelvic congestion. Br J Obstet Gynecol 1989;96:1153-62.
69. Vercellini P, Cortesi I, Crosignani PG. Progestins for symptomatic endometriosis: A critical analysis of the evidence. Fertil Steril 1997;68:393-401.
70. Barbieri RL. Etiology and epidemiology of endometriosis. Am J Obstet Gynecol 1990;162:565-7.
71. Barbieri RL, Ryan KJ. Medical therapy for endometriosis: Endocrine pharmacology. Semin Reprod Endocrinol 1985;3:339-52.
72. Dlugi AM, Miller JD, Knittle J. Lupron Study Group. Lupron depot in the treatment of endometriosis: A randomized, placebo-controlled, double blind study. Fertil Steril 1990;54:419-27.
73. Hornstein MD, Yuzpe AA, Burry KA, et al. Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain. Fertil Steril 1995;63:955-62.
74. Hornstein MD, Surrey ES, Weinberg GW, et al. Leuprolide acetate depot and hormonal add-back in endometriosis: A 12-month study. Obstet Gynecol 1998;91:16-24.
75. Hornstein MD, Hemmings R, Yuzpe AA, et al. Use of nafarelin versus placebo after reductive laparoscopy surgery for endometriosis. Fertil Steril 1997;68:860-4.
76. Hornstein MD, Yuzpe AA, Burry K, et al. Retreatment with nafarelin for recurrent endometriosis symptoms: Efficacy, safety and bone mineral density. Fertil Steril 1997;67:1013-8.
77. Barbieri RL, Ryan KJ. Danazol: Endocrine pharmacology and therapeutic applications. Am J Obstet Gynecol 1981;141:453-63.
78. Barbieri RL, Evans S, Kistner RW. Danazol in the treatment of endometriosis: Analysis of 100 cases with a 4-year follow-up. Fertil Steril 1982;37:737-46.
79. Biberglou KO, Behrman SJ. Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness. Am J Obstet Gynecol 1981;139:645-54.
80. Peters AA, van Dorst E, Jellis B, et al. A randomized clinical trial to compare two different approaches in women with chronic pelvic pain. Obstet Gynecol 1991;77:740-4.
81. Beard RW. Chronic pelvic pain, Br J Obstet Gynecol 1998;105:8-10.
82. Moore J, Kennedy SH. Causes of chronic pelvic pain. Baillieres Clin Obstet Gynaecol 2000;14:389-402.